Cytodyn Inc (CYDY)

[TheBioTechG]

I took part in 1 of Paulson's IPOs for CytoDyn and that is exactly what they preach there - sell your shares for a profit and hold on to 5-year warrants. I could have taken that road and sold at $1.50; however, I view CytoDyn as an investment just as you do. Additionally, the company made it easier for investors to exercise their warrants and sell them.

IMO the SP reflects what the latest offering was at ($0.75/share) and the risk that PRO-140 brings (as it still isn't approved). The science isn't going to change - monoclonal antibodies have proven to be safe (especially PRO-140) and the future of medicine.

The only thing that's bothering me is how long it is taking to fill these trials. Once we get word of combo being filled and first patient for monotherapy being injected, then we'll start to see the SP move up a little because we'll have a firm deadline for trial completion.

It's going to take patience, but I am holding long.